President's Message

DECEMBER 2025

Dear Colleagues and Members,

As we embrace this holiday season, the Clinical Immunology Society remains steadfast in our commitment to advancing our field with determination and collaborative spirit. Our progress is intrinsically tied to your engagement and expertise.

I am delighted to share several important updates and opportunities for deeper involvement within CIS and our broader immunology community. Your active participation represents the most valuable contribution to our collective achievements.

Wherever this message finds you, I extend my warmest wishes for a joyous holiday season and a peaceful winter.

Abstract Deadline Approaching

Deadline to Submit: December 15th

CIS is currently accepting submissions for our 2026 Annual Meeting in New Orleans, Louisiana. This premier convening of clinical immunology's leading minds represents a pivotal opportunity to share groundbreaking research, foster interdisciplinary collaboration, and translate discovery into enhanced patient care.

✓ Renew Your CIS Membership

Membership renewals for the 2026 dues year are now available. Timely renewal ensures uninterrupted access to all CIS benefits, resources, and privileges through December 31, 2026. Your continued membership strengthens our collective voice and impact.

Journal of Human Immunity: Our Shared Legacy

The Clinical Immunology Society proudly champions the Journal of Human Immunity as the cornerstone of our academic mission. Under the visionary leadership of Editor-in-Chief Jean-Laurent Casanova, JHI has rapidly emerged as the definitive venue for transformative immunology research and the authoritative voice of our discipline.

"This is your journal. Together, we will build JHI into the foundational pillar of clinical immunology and a lasting testament to the CIS legacy."

Advance Your Career with CIS

Explore new professional opportunities through our exclusive member resources.

If you would like your opportunity included in a newsletter, please email mhanan@clinimmsoc.org for review and consideration by the CIS leadership.

New Opportunity: Join the PIDTC Community as an Affiliate Site!

The Primary Immune Deficiency Treatment Consortium (PIDTC) is excited to announce a new opportunity for clinicians and investigators who are interested to join the PIDTC as a new Affiliate Site. Affiliate Site designation allows Investigators to collaborate with the PIDTC without the administrative requirement of opening the natural history studies.

As a PIDTC Affiliate Investigator, you can:

Attend the PIDTC Annual Workshop and all video conferences (Scientific Planning Calls, IEI Case Board).
Join and actively contribute to PIDTC Disease Working Groups.
Propose and lead studies using de-identified PIDTC data (in partnership with a Core Site co-investigator)
Earn authorship on manuscripts based on your contribution.

The best part? Affiliate Sites are not required to open IRB protocols, enroll patients, submit data, or receive an R24 subcontract. This minimizes administrative overhead while maximizing scientific engagement.

Interested in joining as an Affiliate Site member? Email Lisa.Lim@ucsf.edu today.

As the year draws to a close and we look to the new one ahead, we encourage you to connect directly. Bring your ideas, questions, and hopes for the future to myself or any CIS leader. We're here, ready to listen and support you as partners in progress.

Let's make the coming year a bright one, together.

Warmly,

Rebecca Marsh, MD, FCIS

CIS President